Skip to main content

Peer Review reports

From: Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

Original Submission
18 Oct 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Nov 2022 Reviewed Reviewer Report - Diego Ripamonti
20 Mar 2023 Reviewed Reviewer Report
16 May 2023 Author responded Author comments - Inès Devred
Resubmission - Version 3
16 May 2023 Submitted Manuscript version 3
4 Jul 2023 Author responded Author comments - Inès Devred
Resubmission - Version 4
4 Jul 2023 Submitted Manuscript version 4
26 Jul 2023 Author responded Author comments - Inès Devred
Resubmission - Version 5
26 Jul 2023 Submitted Manuscript version 5
Publishing
17 Aug 2023 Editorially accepted
4 Sep 2023 Article published 10.1186/s12879-023-08544-x

You can find further information about peer review here.

Back to article page